AlenCiken

CLBS granted regenerative medicine advanced therapy by FDA

Long
NASDAQ:CLBS   None
Caladrius Receives FDA Regenerative Medicine Advanced Therapy Designation for CD34+ Cell Therapy for Treating Refractory Angina

www.caladrius.com/pr...g-refractory-angina/

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.